Indianstockmarket.net is an effort to educate indian investor by providing useful stock news, stock market websites, informative articles, resources to various investment guides.

Yahoo

Google

Thu, 03 Jul 2008 19:39:21 GMT

GlaxoSmithKline to appeal $81 mn verdict in US (The Economic Times)
British pharamaceutical company GlaxoSmithKline PLC says it will appeal a nearly $81 million verdict in a lawsuit that accused it of overcharging a state health insurance program.

Sun, 06 Jul 2008 10:20:30 GMT

Over 100 cos add about Rs 50K cr to M-cap 6 Jul 2008, 1528 hrs IST,PTI (The Times of India)
MUMBAI: All is not lost in the current bear run on Dalal Street, as close to half-a-trillion rupees have been added to investors' wealth by over 100 companies, including blue-chips like Infosys, Cairn India, Satyam and Ranbaxy and also some little known smaller firms.

Sun, 06 Jul 2008 10:28:13 GMT

Over 100 cos add about Rs 50K cr to M-cap (The Times of India)
Close to half-a-trillion rupees have been added to investors' wealth by over 100 companies, including blue-chips like Infosys, Cairn India, Satyam and Ranbaxy and also others.

Wed, 02 Jul 2008 00:17:09 GMT

US jury orders GlaxoSmithKline, Novartis to pay $114 mn price fraud case (The Economic Times)
A jury in Alabama on Tuesday found two major pharmaceutical companies defrauded Alabama in a long-running drug pricing scheme affecting a federal health care program for the poor, and ordered the firms to pay more than $114 million in damages.

Wed, 02 Jul 2008 12:39:26 GMT

GSK to submit Cervarix's final study data for approval (PharmaBiz)
GlaxoSmithKline provided the following update regarding its application to the US Food and Drug Administration (FDA) for approval of Cervarix, its vaccine to prevent cervical cancer.

Wed, 02 Jul 2008 12:11:29 GMT

Europe shares up 1 pc as banks extend gains (The Economic Times)
European shares extended earlier gains to add 1 per cent in late morning trade.

Tue, 01 Jul 2008 20:18:35 GMT

People with HIV living longer, study shows (Reuters via Yahoo! India News)
By Michael Kahn

Thu, 03 Jul 2008 14:37:06 GMT

Studies of Adolor-GlaxoSmithKline's Entereg can resume
Bizjournals.com, NC - Jul 3, 2008
(NASDAQ:ADLR) in a partnership with GlaxoSmithKline (NYSE:GSK), was OK'd by the FDA in May as a treatment for postoperative ileus, a bowel function disorder ...
GlaxoSmithKline (GSK) NewsBite - FDA Says Studies of ... Market Intelligence Center
Adolor: FDA lifts clinical hold on Entereg program Forbes
UPDATE 1-Adolor: FDA lifts hold on bowel drug; GSK may exit deal Reuters
Philadelphia Inquirer - CNNMoney.com
all 35 news articles

Wed, 02 Jul 2008 21:31:12 GMT

The Money Times

FDA panel urges more testing for diabetes drugs
The Associated Press - Jul 2, 2008
GlaxoSmithKline PLC, AstraZeneca and Novartis AG are among the companies developing diabetes treatments to compete in the domestic market, which grew to ...
FDA Panel: Test Diabetes Drugs For Heart Safety Wall Street Journal Blogs
UPDATE 2-US advisers urge higher bar for new diabetes drugs Reuters India
FDA panel urges more testing, tougher standards for diabetes drugs International Herald Tribune
TheMedGuru - CNNMoney.com
all 259 news articles

Mon, 30 Jun 2008 16:06:40 GMT

GlaxoSmithKline responds to FDA's Cervarix query
CNNMoney.com - Jun 30, 2008
NEW YORK (Associated Press) - GlaxoSmithKline PLC said Monday it responded to questions raised by the Food and Drug Administration over the cervical cancer ...

Mon, 30 Jun 2008 19:54:44 GMT

dBTechno

GlaxoSmithKline Cervarix Vaccine Faces FDA Approval Delays
dBTechno, MA - Jun 30, 2008
Washington (dbTechno) - GlaxoSmithKline PLC has come out and stated that a review of their cervical cancer vaccine Cervarix by the FDA will take longer than ...

Tue, 01 Jul 2008 19:59:15 GMT

FDA News Gives Glaxo a Glimmer of Hope
Motley Fool - Jul 1, 2008
GlaxoSmithKline is an active Income Investor pick. To see how dividend-paying stocks can offer both secure income and the opportunity for growth, ...

Mon, 30 Jun 2008 15:44:17 GMT

GlaxoSmithKline responds to FDA's Cervarix questions
Bizjournals.com, NC - Jun 30, 2008
GlaxoSmithKline submitted its response Monday to questions raised by the Food and Drug Administration in December about Cervarix, the company's experimental ...

Wed, 02 Jul 2008 00:10:10 GMT

GSK faces US delay on cancer vaccine
Financial Times, UK - Jul 1, 2008
By Andrew Jack in London GlaxoSmithKline, the UK-based pharmaceutical company, is unlikely to receive US approval for its key cervical cancer vaccine until ...

Directory | Disclaimer

Developed by WorldITLab.

Content by Stock Market Guide